Galenica : 86th Annual General Meeting of Galenica Ltd.: Shareholders approve all proposals submitted by the Board of Directors

_The 86th Annual General Meeting of Galenica Ltd. in Bern was attended by 399 shareholders representing a total of 73.2% of the registered voting shares of Galenica Ltd.

_The shareholders voted in favour of the proposals put forward by the Board of Directors on all items on the agenda. The Annual General Meeting approved the Annual Report and the 2013 Annual Financial Statements of Galenica Ltd. as well as the Consolidated Financial Statements of the Galenica Group for 2013 and discharged the members of the Board of Directors and the Corporate Executive Committee from liability for their activities in 2013. The Annual General Meeting also approved the proposal to renew the authorised share capital for another two years.
The Remuneration Report, submitted to shareholders for a consultative vote for the seventh time, was approved by more than 90%.
Also approved was the dividend of CHF 14.00 (+27.3%, prior year: CHF 11.00) proposed by the Board of Directors, which will be paid to shareholders on 15 May 2014.

Continue

_Galenica is a diversified Group active throughout the health care market which, among other things, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. The Galenica Group enjoys a leading position in all its business sectors - Pharma, Logistics, Retail and Healthcare Information. A large part of the Group's income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).